Yingye Zheng

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Fred Hutch Cancer Center

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

(2023)10.1158/1078-0432.c.6518829

Top 100%

0DataRank

Top 100%0 citations

Dionyssios Katsaros, Shannon J.C. Shan, Irene Rigault de la Longrais, Mauro Porpiglia, Andreas Scorilas +7 more

Papers

Driven by 30 papers — median percentile 0. Top paper: “A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors”.

A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-0929

N/A

0.571DataRank · unranked

44 citations

Xinwei Hua, Aung Ko Win, Robert J. MacInnis, Steven Gallinger, Loı̈c Le Marchand +9 more

Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond

Preventive Medicine(2021)10.1016/j.ypmed.2021.106595

N/A

0.515DataRank · unranked

30 citations

Douglas A. Corley, Jennifer Elston Lafata, Jennifer S. Haas, John M. Inadomi, Aruna Kamineni +4 more

Designing Rigorous and Efficient Clinical Utility Studies for Early Detection Biomarkers

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-1594

N/A

0.269DataRank · unranked

5 citations

Paul D. Wagner, Amit G. Singal, Samir Hanash, Sudhir Srivastava, Ying Huang +7 more

Biomarker evaluation under imperfect nested case‐control design

Statistics in Medicine(2021)10.1002/sim.9012

N/A

0.104DataRank · unranked

1 citations

Yingye Zheng, Majken K. Jensen, Zhe He, Tianxi Cai, Xuan Wang

Two-phase stratified sampling and analysis for predicting binary outcomes

Biostatistics(2021)10.1093/biostatistics/kxab044

N/A

0DataRank · unranked

8 citations

Sebastien Haneuse, Yingye Zheng, Jinbo Chen, Yaqi Cao

Associations between Genetic Variants and Blood Biomarkers of One-Carbon Metabolism in Postmenopausal Women from the Women's Health Initiative Observational Study

Journal of Nutrition(2021)10.1093/jn/nxab444

N/A

0DataRank · unranked

7 citations

Mmadili N. Ilozumba, Yesilda Balavarca, Marian L. Neuhouser, Joshua W. Miller, Shirley A.A. Beresford +9 more

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer(2021)10.1002/cncr.33911

N/A

0DataRank · unranked

8 citations

Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks +15 more

Re‐calibrating pure risk integrating individual data from two‐phase studies with external summary statistics

Biometrics(2021)10.1111/biom.13543

N/A

0DataRank · unranked

5 citations

Yingye Zheng, Li Hsu, Jiayin Zheng

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0100

N/A

0DataRank · unranked

29 citations

Aruna Kamineni, Andrea N. Burnett‐Hartman, Brian Hixon, Sarah C. Kobrin, Christopher I. Li +20 more

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines

Annals of Internal Medicine(2022)10.7326/m22-1139

N/A

0DataRank · unranked

22 citations

V. Paul Doria‐Rose, Jessica Chubak, John M. Inadomi, Douglas A. Corley, Jennifer S. Haas +12 more

New weighting methods when cases are only a subset of events in a nested case‐control study

Biometrical Journal(2022)10.1002/bimj.202100194

N/A

0DataRank · unranked

7 citations

Xuan Wang, Yingye Zheng, Tianxi Cai, Qian M. Zhou

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine(2022)10.1002/cam4.4778

N/A

0DataRank · unranked

10 citations

Lisa F. Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar +16 more

Targeted Search for Individualized Clinical Decision Rules to Optimize Clinical Outcomes

Statistics in Biosciences(2022)10.1007/s12561-022-09343-9

N/A

0DataRank · unranked

2 citations

Ying‐Qi Zhao, Yingye Zheng, Yanqing Wang

Development of an Electronic Health Record–Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium

JCO Clinical Cancer Informatics(2023)10.1200/cci.23.00063

N/A

0DataRank · unranked

7 citations

J. David Powers, Brian Hixon, Nikki M. Carroll, Timothy B. Frankland, Stacey Honda +8 more

Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-22-0817

N/A

0DataRank · unranked

6 citations

Lori C. Sakoda, Jihyoun Jeon, Minta Thomas, Yi Lin, Jennifer L. Schneider +57 more

Constructing Time-Invariant Dynamic Surveillance Rules for Optimal Monitoring Schedules

Biometrics(2023)10.1111/biom.13911

N/A

0DataRank · unranked

2 citations

Yingye Zheng, Daniel W. Lin, Lisa F. Newcomb, Ying‐Qi Zhao, Xinyuan Dong

Data from A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

(2023)10.1158/1078-0432.c.6518829

Top 100%

0DataRank

Top 100%0 citations

Dionyssios Katsaros, Shannon J.C. Shan, Irene Rigault de la Longrais, Mauro Porpiglia, Andreas Scorilas +7 more

Data from A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

(2023)10.1158/1078-0432.c.6518829.v1

Top 100%

0DataRank

Top 100%0 citations

Dionyssios Katsaros, Shannon J.C. Shan, Irene Rigault de la Longrais, Mauro Porpiglia, Andreas Scorilas +7 more

Designing cancer screening trials for reduction in late-stage cancer incidence

Biometrics(2024)10.1093/biomtc/ujae097

N/A

0DataRank · unranked

1 citations

Ying‐Qi Zhao, Yingye Zheng, Kehao Zhu

Weighted Brier Score -- an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration

arXiv (Cornell University)(2024)10.48550/arxiv.2408.01626

N/A

0DataRank · unranked

0 citations

Yingye Zheng, Kwun Chuen Gary Chan, Kehao Zhu

Weighted Brier Score—An Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration

Statistics in Biosciences(2025)10.1007/s12561-025-09505-5

N/A

0DataRank · unranked

5 citations

Yingye Zheng, Kwun Chuen Gary Chan, Kehao Zhu

A simplified MyProstateScore2.0 for high-grade prostate cancer

Cancer Biomarkers(2025)10.1177/18758592241308755

N/A

0DataRank · unranked

1 citations

Yuping Zhang, Ana Kenney, Cassie Xie, Lanbo Xiao, Javed Siddiqui +10 more

Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study

Statistics in Medicine(2025)10.1002/sim.70072

N/A

0DataRank · unranked

0 citations

Tianxi Cai, Lisa F. Newcomb, Daniel Lin, Yingye Zheng, Yunro Chung

Estimating optimally tailored active surveillance strategy under interval censoring

Biometrics(2025)10.1093/biomtc/ujaf067

N/A

0DataRank · unranked

0 citations

Ying‐Qi Zhao, Daniel W. Lin, Matthew R. Cooperberg, Yingye Zheng, Muxuan Liang

Gaps in care across the cancer screening continuum for cervical, colorectal, and lung cancers

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf248

N/A

0DataRank · unranked

0 citations

Kaitlin Todd, Dale McLerran, Jasmin A. Tiro, Anil Vachani, Sarah C. Kobrin +9 more

Associations between Plasma Choline Metabolites and Genetic Polymorphisms in One-Carbon Metabolism in Postmenopausal Women: The Women's Health Initiative Observational Study

Journal of Nutrition(2020)10.1093/jn/nxaa266

N/A

0DataRank · unranked

14 citations

Ting‐Yuan David Cheng, Marian L. Neuhouser, Joshua W. Miller, Shirley A.A. Beresford, David Duggan +10 more

Supplementary Methods from Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort

Figshare(2025)10.1158/1055-9965.30723154

Top 100%

0DataRank

Top 100%0 citations

Lori C. Sakoda, Jihyoun Jeon, Minta Thomas, Yi Lin, Jennifer L. Schneider +57 more

Developing and evaluating risk prediction models with panel current status data

Biometrics(2020)10.1111/biom.13317

N/A

0DataRank · unranked

2 citations

Xuan Wang, Ina Jazić, Sarah B. Peskoe, Yingye Zheng, Tianxi Cai +1 more

Association between post-treatment circulating biomarkers of inflammation and survival among stage II–III colorectal cancer patients

British Journal of Cancer(2021)10.1038/s41416-021-01458-y

N/A

0DataRank · unranked

24 citations

Mario Kratz, Rachel C. Malen, James Y. Dai, Sara Lindström, Yingye Zheng +2 more

Risk Projection for Time-to-Event Outcome Leveraging Summary Statistics With Source Individual-Level Data

Journal of the American Statistical Association(2021)10.1080/01621459.2021.1895810

N/A

0DataRank · unranked

13 citations

Yingye Zheng, Li Hsu, Jiayin Zheng

Yingye Zheng

Indexed papers

Top data-sharing exemplar

Papers